Aspirin-Exacerbated Respiratory Disease | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

100,453 results for “Aspirin-Exacerbated Respiratory Disease”

Trials

View all 76735 →

Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban

38 participants · First posted Oct 30, 2017

Active, not recruiting

Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease

17 participants · First posted Oct 12, 2022

Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)

46 participants · First posted May 14, 2012

Drugs

View all 1653 →

undisclosed respiratory program (respiratory disease)

undisclosed respiratory disease program (respiratory diseases)

Respiratory disease therapy(Aphoenix)

Organizations

View all 260 →

Rare Disease Research, LLC

Pneuma Respiratory, Inc.

United States

Japanese Respiratory Society

Japan

News

View all 21805 →

Pulmonology in 2024: AI Integration, Air Quality Crisis, and Advancing Lung Care Highlighted in Annual Review

Mepolizumab Demonstrates Sustained Efficacy in Chronic Rhinosinusitis with Nasal Polyps: Real-World Evidence

Tezspire Meets Primary Endpoints in Phase 3 WAYPOINT Trial for Chronic Rhinosinusitis with Nasal Polyps

Page 1 of 10046